Galidesivir hydrochloride
≥99%
- Product Code: 60299
CAS:
222631-44-9
| Molecular Weight: | 301.73 g./mol | Molecular Formula: | C₁₁H₁₆ClN₅O₃ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
Galidesivir hydrochloride is primarily investigated for its antiviral properties, particularly against RNA viruses. It has shown potential in treating infections caused by viruses such as Ebola, Marburg, and Zika. The compound works by inhibiting viral RNA polymerase, thereby preventing viral replication. Clinical studies have explored its efficacy in reducing viral load and improving patient outcomes in severe viral infections. Additionally, it has been considered for use in combating emerging viral threats due to its broad-spectrum antiviral activity. Research continues to evaluate its safety, effectiveness, and potential as a therapeutic option in both human and veterinary medicine.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | £1,289.17 |
+
-
|
| 0.005 | 10-20 days | £5,428.08 |
+
-
|
Galidesivir hydrochloride
Galidesivir hydrochloride is primarily investigated for its antiviral properties, particularly against RNA viruses. It has shown potential in treating infections caused by viruses such as Ebola, Marburg, and Zika. The compound works by inhibiting viral RNA polymerase, thereby preventing viral replication. Clinical studies have explored its efficacy in reducing viral load and improving patient outcomes in severe viral infections. Additionally, it has been considered for use in combating emerging viral threats due to its broad-spectrum antiviral activity. Research continues to evaluate its safety, effectiveness, and potential as a therapeutic option in both human and veterinary medicine.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :